Publications & Research
Study: PET predicts survival from sarcomas
Researchers from the Jonsson Comprehensive Cancer Center at UCLA studied 39 patients with soft-tissue sarcoma who received a PET scan to measure tumor metabolism prior to chemotherapy. The patients also were given a PET scan after the first round of chemotherapy.
Patients whose tumors demonstrated a 25% or more decrease in metabolic activity were determined later to have significant increased survival rates compared to those patients who had less than a 25% decrease, according to senior study author Dr. Fritz Eilber, associate professor of surgical oncology and director of the sarcoma program at the cancer center.